+データを開く
-基本情報
登録情報 | データベース: PDB / ID: 4gl9 | ||||||
---|---|---|---|---|---|---|---|
タイトル | Crystal structure of inhibitory protein SOCS3 in complex with JAK2 kinase domain and fragment of GP130 intracellular domain | ||||||
要素 |
| ||||||
キーワード | transferase/transferase inhibitor / kinase inhibitor receptor cytokine signalling / phosphorylation / transferase-transferase inhibitor complex | ||||||
機能・相同性 | 機能・相同性情報 response to granulocyte macrophage colony-stimulating factor / IFNG signaling activates MAPKs / positive regulation of cell activation / Regulation of IFNG signaling / PTK6 Activates STAT3 / Growth hormone receptor signaling / Signaling by Erythropoietin / Interleukin-4 and Interleukin-13 signaling / oncostatin-M receptor activity / Prolactin receptor signaling ...response to granulocyte macrophage colony-stimulating factor / IFNG signaling activates MAPKs / positive regulation of cell activation / Regulation of IFNG signaling / PTK6 Activates STAT3 / Growth hormone receptor signaling / Signaling by Erythropoietin / Interleukin-4 and Interleukin-13 signaling / oncostatin-M receptor activity / Prolactin receptor signaling / IL-6-type cytokine receptor ligand interactions / Interleukin-20 family signaling / leukemia inhibitory factor receptor activity / MAPK3 (ERK1) activation / MAPK1 (ERK2) activation / Interferon gamma signaling / Interleukin-12 signaling / Interleukin-27 signaling / Signaling by CSF3 (G-CSF) / Erythropoietin activates RAS / triglyceride mobilization / Interleukin-23 signaling / interleukin-6 receptor activity / interleukin-6 binding / Interleukin-6 signaling / Interleukin-35 Signalling / Interferon alpha/beta signaling / oncostatin-M receptor complex / ciliary neurotrophic factor receptor binding / Inactivation of CSF3 (G-CSF) signaling / Signaling by SCF-KIT / ciliary neurotrophic factor receptor complex / RAF activation / interleukin-27-mediated signaling pathway / interleukin-6 receptor complex / Cyclin D associated events in G1 / Erythropoietin activates Phosphoinositide-3-kinase (PI3K) / negative regulation of tyrosine phosphorylation of STAT protein / Interleukin receptor SHC signaling / RAF/MAP kinase cascade / regulation of Notch signaling pathway / interleukin-6 receptor binding / branching involved in labyrinthine layer morphogenesis / interleukin-11-mediated signaling pathway / cellular response to interleukin-17 / negative regulation of heart contraction / Factors involved in megakaryocyte development and platelet production / placenta blood vessel development / nuclear receptor-mediated mineralocorticoid signaling pathway / histone H3Y41 kinase activity / : / positive regulation of growth factor dependent skeletal muscle satellite cell proliferation / Interleukin-3, Interleukin-5 and GM-CSF signaling / symbiont-induced defense-related programmed cell death / mammary gland epithelium development / regulation of postsynapse to nucleus signaling pathway / positive regulation of growth hormone receptor signaling pathway / Neddylation / positive regulation of astrocyte differentiation / granulocyte macrophage colony-stimulating factor receptor complex / granulocyte-macrophage colony-stimulating factor signaling pathway / Antigen processing: Ubiquitination & Proteasome degradation / collagen-activated signaling pathway / intestinal epithelial cell development / interleukin-12 receptor binding / 1-phosphatidylinositol-3-kinase regulator activity / response to interleukin-12 / interleukin-5-mediated signaling pathway / myeloid cell differentiation / post-embryonic hemopoiesis / protein tyrosine kinase inhibitor activity / interleukin-12 receptor complex / activation of Janus kinase activity / tyrosine phosphorylation of STAT protein / interleukin-23 receptor complex / positive regulation of platelet aggregation / positive regulation of T-helper 17 type immune response / positive regulation of MHC class II biosynthetic process / interleukin-12-mediated signaling pathway / acetylcholine receptor binding / type 1 angiotensin receptor binding / positive regulation of NK T cell proliferation / positive regulation of platelet activation / interleukin-3-mediated signaling pathway / cellular response to interleukin-3 / regulation of nitric oxide biosynthetic process / positive regulation of signaling receptor activity / phosphatidylinositol 3-kinase complex / positive regulation of epithelial cell apoptotic process / positive regulation of natural killer cell proliferation / positive regulation of cell-substrate adhesion / cytokine receptor activity / growth hormone receptor binding / miRNA binding / growth hormone receptor signaling pathway / axon regeneration / response to hydroperoxide / negative regulation of cardiac muscle cell apoptotic process / intrinsic apoptotic signaling pathway in response to oxidative stress / peptide hormone receptor binding 類似検索 - 分子機能 | ||||||
生物種 | Mus musculus (ハツカネズミ) | ||||||
手法 | X線回折 / シンクロトロン / 分子置換 / 解像度: 3.9 Å | ||||||
データ登録者 | Kershaw, N.J. / Murphy, J.M. / Laktyushin, A. / Nicola, N.A. / Babon, J.J. | ||||||
引用 | ジャーナル: Nat.Struct.Mol.Biol. / 年: 2013 タイトル: SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition. 著者: Kershaw, N.J. / Murphy, J.M. / Liau, N.P. / Varghese, L.N. / Laktyushin, A. / Whitlock, E.L. / Lucet, I.S. / Nicola, N.A. / Babon, J.J. | ||||||
履歴 |
|
-構造の表示
構造ビューア | 分子: MolmilJmol/JSmol |
---|
-ダウンロードとリンク
-ダウンロード
PDBx/mmCIF形式 | 4gl9.cif.gz | 347.2 KB | 表示 | PDBx/mmCIF形式 |
---|---|---|---|---|
PDB形式 | pdb4gl9.ent.gz | 284.1 KB | 表示 | PDB形式 |
PDBx/mmJSON形式 | 4gl9.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
その他 | その他のダウンロード |
-検証レポート
文書・要旨 | 4gl9_validation.pdf.gz | 1.3 MB | 表示 | wwPDB検証レポート |
---|---|---|---|---|
文書・詳細版 | 4gl9_full_validation.pdf.gz | 1.4 MB | 表示 | |
XML形式データ | 4gl9_validation.xml.gz | 66.8 KB | 表示 | |
CIF形式データ | 4gl9_validation.cif.gz | 82.8 KB | 表示 | |
アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/gl/4gl9 ftp://data.pdbj.org/pub/pdb/validation_reports/gl/4gl9 | HTTPS FTP |
-関連構造データ
-リンク
-集合体
登録構造単位 |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
2 |
| ||||||||
3 |
| ||||||||
4 |
| ||||||||
単位格子 |
|
-要素
#1: タンパク質 | 分子量: 35111.883 Da / 分子数: 4 / 断片: Kinase domain (unp residues 836-1132) / 由来タイプ: 組換発現 / 由来: (組換発現) Mus musculus (ハツカネズミ) / 遺伝子: Jak2, mCG_9104 発現宿主: Spodoptera frugiperda (ツマジロクサヨトウ) 参照: UniProt: G5E852, UniProt: Q62120*PLUS, non-specific protein-tyrosine kinase #2: タンパク質・ペプチド | 分子量: 1605.573 Da / 分子数: 4 / 断片: unp residues 750-764 / 由来タイプ: 合成 / 由来: (合成) Mus musculus (ハツカネズミ) / 参照: UniProt: Q00560 #3: タンパク質 | 分子量: 15641.506 Da / 分子数: 4 断片: chimeric fusion of Intracellular domain (unp residues 22-128 and 163-185) 由来タイプ: 組換発現 / 由来: (組換発現) Mus musculus (ハツカネズミ) / 遺伝子: Socs3, Cis3, Cish3 / 発現宿主: Escherichia coli (大腸菌) / 参照: UniProt: O35718 #4: 化合物 | ChemComp-IZA / #5: 化合物 | ChemComp-PO4 / | Has protein modification | Y | |
---|
-実験情報
-実験
実験 | 手法: X線回折 / 使用した結晶の数: 1 |
---|
-試料調製
結晶 | マシュー密度: 4.23 Å3/Da / 溶媒含有率: 70.95 % |
---|---|
結晶化 | 温度: 298 K / 手法: 蒸気拡散法, ハンギングドロップ法 / pH: 4.2 詳細: 0.33M di-potassium hydrogen phosphate, 1.67M sodium dihydrogen phosphate, 0.1M phosphate-citrate, pH 4.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K |
-データ収集
回折 | 平均測定温度: 100 K |
---|---|
放射光源 | 由来: シンクロトロン / サイト: Australian Synchrotron / ビームライン: MX2 / 波長: 0.95371 Å |
検出器 | タイプ: ADSC QUANTUM 315r / 検出器: CCD / 日付: 2011年4月2日 |
放射 | モノクロメーター: Si 111 CHANNEL / プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 0.95371 Å / 相対比: 1 |
反射 | 解像度: 3.9→45.584 Å / Num. obs: 31617 / % possible obs: 99.9 % / Observed criterion σ(F): 0 / Observed criterion σ(I): -3 |
-解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: 分子置換 / 解像度: 3.9→45.58 Å / σ(F): 1.99 / 位相誤差: 36.69 / 立体化学のターゲット値: TWIN_LSQ_F
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | 減衰半径: 0.9 Å / VDWプローブ半径: 1.11 Å / 溶媒モデル: FLAT BULK SOLVENT MODEL | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 3.9→45.58 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LS精密化 シェル |
|